Comments

Veracyte Stock Price, Quotes and Forecasts

Q: What sector and industry does Veracyte (VCYT) operate in?

Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VCYTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$26.96

0.240.90%

At close: -

$26.96

0.000.00%

After Hours: 4:33 PM EDT

Veracyte (VCYT) Forecast

News Earnings Veracyte (VCYT) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Veracyte Stock Price, Quotes and Forecasts | NASDAQ:VCYT | Benzinga

Explore Veracyte stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VCYT.

Open	$27.18
Close	$26.96
Volume / Avg.	878.86K / 1.04M
Day Range	$26.27 - $27.32
52 Wk Range	19.73 - 47.32
Market Cap	$2.11B
P/E Ratio	63.62
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	7.43%
Days to Cover	3.88

Recent News

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics, Offloads Meta Platforms

ARK Invest made significant trades in NTLA, META, VCYT, SYM, BIDU, and PATH. These moves come amidst changes in stock prices. Read more for full details.

Rounak Jain

Analyst Sees Bottom For Myriad Genetics Stock, Issues Upgrade

Piper Sandler upgrades Myriad Genetics to Overweight, citing stock stabilization and new leadership. The firm raises its price target to $12.50.

Vandana Singh

Diagnostic Company Veracyte Weighs Sale For French Subsidiary, Analyst Says 'Walking Away' Is A Long-Term Positive

Veracyte topped Q4 earnings and revenue estimates as testing volume grew. The company is evaluating options for its French unit.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$27.18
Close	$26.96
Volume / Avg.	878.86K / 1.04M
Day Range	$26.27 - $27.32
52 Wk Range	19.73 - 47.32
Market Cap	$2.11B
P/E Ratio	63.62
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	7.43%
Days to Cover	3.88

About Veracyte Inc

Sector

Health Care

Industry

Biotechnology

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights neces...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Veracyte (VCYT) stock?

You can purchase shares of Veracyte (NASDAQ:VCYT) through any online brokerage.

View our list of the best stock brokerages

Who are Veracyte (VCYT) competitors?

Other companies in Veracyte’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA) and MoonLake (NASDAQ:MLTX).

What is the forecast, or price target, for Veracyte (VCYT) stock?

Veracyte has a consensus price target of $39.40.

What is the current price for Veracyte (VCYT)?

The stock price for Veracyte (NASDAQ: VCYT) is $26.96 last updated May 29, 2025 at 4:33 PM EDT.

Does Veracyte (VCYT) pay a dividend?

There are no upcoming dividends for Veracyte.

When is Veracyte (NASDAQ:VCYT) reporting earnings?

Veracyte’s Q2 earnings are confirmed for Tuesday, August 5, 2025.

Is Veracyte (VCYT) going to split?

There is no upcoming split for Veracyte.

What sector and industry does Veracyte (VCYT) operate in?

Veracyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.